Memantine Hydrochloride

็›้…ธ็พŽ้‡‘ๅˆš

Report date: 2026/05/20 20:02:01
NMEFirst In Class

Base Information

Drug NameMemantine Hydrochloride
Drug Alias NameไบŒ็”ฒๅŸบ้‡‘ๅˆš่ƒบ็›้…ธ็›Memantina็พŽ้‡‘ๅˆš่ƒบ็›้…ธ็›Memantinum็›้…ธ็พŽ้‡‘ๅˆš่ƒบ +[19]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsBrain metastasesIschemic StrokeSolid tumours +[65]ย 
Global Approved IndicationsAlzheimer Disease
Approved Indications in ChinaAlzheimer Disease
Original Approved Country/TerritoryEU
Original Approved Date2002/05/15
Country/TerritoryBelgiumCanadaUnited States +[31]ย 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerz Pharma
China Registration ClassN/A

Other Information

ATC CodeN06DX01